The annualized cumulative incidence rate of contralateral breast cancer among unilateral breast cancer cases with germline PVs in BRCA1 and BRCA2 genes is 2.3% and 1.7% per year, respectively [49,50]. This evidence concerns the gene BRCA2 and breast cancer.